Evidence-Based Medicine Guidelines
Chemotherapy versus combined modality treatment in Hodgkin's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy Versus Combined Modality Treatment in Hodgkin's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456294/all/Chemotherapy_versus_combined_modality_treatment_in_Hodgkin's_disease.
Chemotherapy versus combined modality treatment in Hodgkin's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456294/all/Chemotherapy_versus_combined_modality_treatment_in_Hodgkin's_disease. Accessed June 9, 2023.
Chemotherapy versus combined modality treatment in Hodgkin's disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456294/all/Chemotherapy_versus_combined_modality_treatment_in_Hodgkin's_disease
Chemotherapy Versus Combined Modality Treatment in Hodgkin's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456294/all/Chemotherapy_versus_combined_modality_treatment_in_Hodgkin's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy versus combined modality treatment in Hodgkin's disease
ID - 456294
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456294/all/Chemotherapy_versus_combined_modality_treatment_in_Hodgkin's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
